1350 Neo-open reading frame peptides as a source of highly immunogenic neoantigens for mRNA therapeutic cancer vaccines

• Michael Martin,
• Regina Heidenreich,
• Wigard Kloosterman,
• Hugo Olsman,
• Katka Franke,
• Ronja Isabelle Mülfarth,
• Salvador Aguilar-Rosas,
• Mark Pieterse,
• Jamie Langelaar,
• Wim van Esch,
• Renee van Schreurs,
• Lisa van der Made,
• Bob Löwenberg,
• Ronald Plasterk,
• Janna Krüger

Affiliations

Michael Martin

1University of California, San Francisco, San Francisco, CA, USA

Regina Heidenreich

2CureVac, Tübingen, Baden-Württemberg, Germany

Wigard Kloosterman

1CureVac Netherlands B.V., Amsterdam, Netherlands

Hugo Olsman

1CureVac Netherlands B.V., Amsterdam, Netherlands

Katka Franke

1CureVac Netherlands B.V., Amsterdam, Netherlands

Ronja Isabelle Mülfarth

2CureVac, Tübingen, Baden-Württemberg, Germany

Salvador Aguilar-Rosas

1CureVac Netherlands B.V., Amsterdam, Netherlands

Mark Pieterse

1CureVac Netherlands B.V., Amsterdam, Netherlands

Jamie Langelaar

1CureVac Netherlands B.V., Amsterdam, Netherlands

Wim van Esch

1CureVac Netherlands B.V., Amsterdam, Netherlands

Renee van Schreurs

1CureVac Netherlands B.V., Amsterdam, Netherlands

Lisa van der Made

1CureVac Netherlands B.V., Amsterdam, Netherlands

Bob Löwenberg

1CureVac Netherlands B.V., Amsterdam, Netherlands

Ronald Plasterk

1CureVac Netherlands B.V., Amsterdam, Netherlands

Janna Krüger

2CureVac, Tübingen, Baden-Württemberg, Germany